Collaborations aim to develop new drugs for neglected tropical diseases
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2638 (Published 29 June 2009) Cite this as: BMJ 2009;338:b2638- Janice Hopkins Tanne
- 1New York
The Drugs for Neglected Diseases Initiative meeting in Nairobi, Kenya, on 23 June heard promising news about collaborations to develop drugs to treat neglected tropical diseases.
The meeting brought together more than 200 scientists, researchers, academics, and global health leaders from Africa and abroad to consider new treatments for diseases such as visceral leishmaniasis (kala-azar), Chagas’ disease, and sleeping sickness.
The initiative said that better treatments are needed by millions of the world’s poorest people. Current treatments are often toxic, prohibitively expensive, or difficult to administer in countries with limited resources. Drug companies have little incentive to develop treatments for neglected diseases that mainly …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.